Pathophysiology of Schizophrenia

Schizophrenia: Current Science and Clinical Practice

Volumn , Issue , 2011, Pages 31-65

  Falkai, Peter ^a   Schmitt, Andrea ^a   Cannon, Tyrone D ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

'dementia praecox'; Cerebrospinal fluid (CSF); D amino acid oxidase (DAAO); Gamma butyric acid (GABA); Magnetic resonance imaging (MRI); N methyl D aspartate (NMDA); Pathophysiology of schizophrenia; Positron Emission Tomography (PET); Prepulse inhibition (PPI)

Indexed keywords

EID: 84862526597     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470978672.ch2     Document Type: Chapter

References (250)

1. Murray CJ, Lopez AD. (1996) Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 274(5288), 740-743.
2. Watt DC, Katz K, Sheperd M (1983) The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment. Psychol Med 13(3), 663-670.
3. Häfner H, an der Heiden W (2003) Course and outcome of schizophrenia. In: Hirsch&Weinberger (Hrsg.). Schizophrenia,Blackwell Publishing, Oxford, pp. 101-139.
4. Andreasen NC, Arndt S, AlligerRet al. (1995) Symptoms of schizophrenia. Methods, meaning, and mechanisms. Arch Gen Psychiatry 52, 341-351.
5. Liddle PF (1987) The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br J Psychiatry 161, 861.
6. Lindenmayer JP, Grochowski S, Hyman RB (1995) Five factor model of schizophrenia: replication across symples. Schizophr Res 14, 229-234.
7. Toomey R, Kremen WS, Simpson JC et al. (1997) Revisiting the factor structure for positive and negative symptoms: evidence from a large heterogeneous group of psychiatric patients. Am J Psychiatry 154, 371-377.
8. Toomey R, Faraone SV, Simpson JC et al. (1998) Negative, positive and disorganized symptom dimensions in schizophrenia, major depression, and bipolar disorder.JNerv Ment Dis 186, 470-476.
9. Kraepelin E (1919) Dementia praecox and paraphrenia. Edinburgh: Livingstone.
10. Crow TJ (1980) Molecular pathology of schizophrenia: more than one disease process? Br Med J 280, 66-68.
11. AndreasenNC(1982) Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry 39, 784-788.
12. Albus M, Hubmann W, Scherer J et al. (2002) A prospective 2-year follow-up study of neurocognitive functioning in patients with first-episode schizophrenia. Eur Arch Psychiatry Clin Neurosci 252(6), 262-267.
13. Albus M, Hubmann W, Mohr F et al. (2006) Neurocognitive functioning in patients with first-episode schizophrenia: results of a prospective 5-year follow-up study. Eur Arch Psychiatry Clin Neurosci 256(7), 442-451.
14. Hoff AL, Harris D, Faustman WO et al. (1996) A neuropsychological study of early onset schizophrenia. Schizophr Res 20(1-2), 21-28.
15. Hoff AL, Svetina C, Shields G et al. (2005) Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia. Schizophr Res 78(1):27-34.
16. Heinrichs RW, Zakzanis KK (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12(3), 426-445.
17. McGurk SR, Meltzer HY (2000) The role of cognition in vocational functioning in schizophrenia. Schizophr Res 45, 175-184.
18. Holthausen EA, Wiersma D, Cahn W et al. (2007) Predictive value of cognition for different domains of outcome in recent-onset schizophrenia. Psychiatry Res 149(1-3), 71-80.
19. Robinson DG,Woerner MG, Alvir JM et al. (2002) Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophr Res 57(2-3): 209-219.
20. Andreasen NC, Carpenter WT Jr, Kane JM et al. (2005) Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 162(3):441-449.
21. HeinrichsDW, Buchanan RW(1988) Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry 145, 11-18.
22. Tsuang MT, Faraone SV (1999) The concept of target features in schizophrenia research. Acta Psychiatr Scand Suppl 395, 2-11.
23. Chen EY, Shapleske J, Luque R et al. (1995) The Cambridge Neurological Inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Res 56, 183-204.
24. Levy DL, Holzman PS, Matthyse S et al. (1994) Eye tracking and schizophrenia: a selective review. Schizophr Bull 20, 47-62.
25. Thaker GK, Ross DE,Cassady SL et al. (2000) Saccadic eye movement abnormalities in relatives of patients with schizophrenia. Schizophr Res 45, 235-244.
26. Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156, 234-258.
27. Jaber M, Robinson SW, Missale C et al. (1996) Dopamine receptors and brain function. Neuropsychopharmacology 35(11), 1503-1519.
28. Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 271, 93-96.
29. Carlsson A (1995) The dopamine theory revisited. In: Hirsch SR, Weinberger DR (eds.) Schizophrenia, Blackwell Science, Oxford, pp. 379-400.
30. Seeman P, Lee T, Chau-Wong M et al. (1976) Antipsychotic drug doses and neuroleptic/ DA receptors. Nature 261, 717-719.
31. Angrist B, van Kammen DP (1984) CNS stimulants as a tool in the study of schizophrenia. Trends Neurosci 7, 388-390.
32. Lieberman JA, Kane JM, Alvir J (1987) provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology 91, 415-433.
33. Laruelle M, Abi-Dargham A, van Dyck CH et al. (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93(17), 9235-9240.
34. Breier A, Su T-P, Saunders R et al. (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 94, 2569-2574.
35. Abi-Dargham A, Gil R, Krystal J et al. (1998) Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 155, 761-767.
36. Laruelle M, Abi-Dargham A, Gil R et al. (1999) Increased dopamine transmission in schizophrenia: Relationship to illness phases. Biol Psychiatry 46, 56-72.
37. Davis KL, Kahn RS, Ko G et al. (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148, 1474-1486.
38. Crow TJ (1980) Molecular pathology of schizophrenia: More than one disease process? Br Med J 280, 66-68.
39. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148, 1301-1308.
40. Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20, 201-225.
41. Krystal JH, Karper LP, Seibyl JP et al. (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51, 199-214.
42. LahtiAC,Koffel B, LaPorteDet al. (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13, 9-19.
43. Grace AA (1991) Phasic versus tonic dopamine release and the modulation of dopamine system resposivity: A hypothesis for the etiology of schizophrenia. Neuroscience 41(1), 1-24.
44. Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52, 998-1007.
45. Jentsch JD, Redmond DE Jr, Elsworth JD et al. (1997) Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science 277(5328), 953-955.
46. Farber NB, Newcomer JW, Olney JW (1999) Glycine agonists: what can they teach us about schizophrenia? Arch Gen Psychiatry 56, 13-17.
47. Harrison PJ, Weinberger DR (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10(1), 40-68.
48. Ozaki M, Sasner M, Yano R et al. (1997) Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature 390(6661), 691-694.
49. Jentsch JD, Trantham-Davidson H, Jairl C (2009) Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice. Neuropsychopharmacology 34(12), 2601-2608.
50. Johnstone EC, Crow TJ, Frith CD et al. (1976) Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 2(7992), 924-926.
51. Kovelman JA, Scheibel AB (1984) A neurohistological correlate of schizophrenia. Biol Psychiatry 19(12), 1601-1621.
52. Wright IC, Rabe-Hesketh S, Woodruff PW et al. (2000) Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157(1), 16-25.
53. Shenton ME, Dickey CC, Frumin M et al. (2001) A review of MRI findings in schizophrenia. Schizophr Res 49, 1-52.
54. Crow TJ (1990) Temporal lobe asymmetries as the key to the etiology of schizophrenia. Schizophr Bull 16, 433-443.
55. Falkai P, Bogerts B, Schneider T (1995) Disturbed planum temporale asymmetry in schizophrenia. A quantitative post-mortem study. Schizophr Res 14, 161-176.
56. Falkai P, Honer WG, Alfter D, Schneider-Axmann, T et al. (2002) The temporal lobe in schizophrenia from uni-and multiply affected families. Neurosci Lett 325, 25-28.
57. Greenwood R, Bhalla A, Gordon A et al. (1983) behavior disturbances during recovery from herpes simplex encephalopathy. J Neurol Neurosurg Psychiatry 46, 809-817.
58. Bogerts B (1997) The temporolimbic system theory of positive schizophrenic symptoms. Schizophr Bull 23, 423-435.
59. Heckers S (2001) Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus 11, 520-528.
60. Bogerts B, Falkai P, Haupts M et al. (1990) Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection. Schizophr Res 3, 295-301.
61. Bogerts B, Lieberman JA, Ashtari M et al. (1993) Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biol Psychiatry 33, 236-246.
62. Heckers S, Konradi C (2002) Hippocampal neurons in schizophrenia. J Neural Transm 109, 891-905.
63. FanselowMS, DongHW(2010) Are the dorsal and ventral hippocampus functionally distinct structures? Neuron 65, 7-19.
64. Becker T, ElmerK, Schneider F et al. (1996) Confirmation of reduced temporal limbic structure volume onmagnetic resonance imaging in male patientswith schizophrenia. Psychiatry Res 67, 135-143.
65. Hirayasu Y, Shenton ME, Salisbury DF et al. (1998) Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. Am J Psychiatry 155, 1384-1391.
66. Narr KL, Thompson PM, Sharma T et al. (2001) Three-dimensional mapping of temporo-limbic regions and the lateral ventricles in schizophrenia: gender effects. Biol Psychiatry 50, 84-97.
67. Velakoulis D, Stuart GW, Wood SJ, et al. (2001) Selective bilateral hippocampal volume loss in chronic schizophrenia. Biol Psychiatry 50, 531-539.
68. Yamasue H, Iwanami A, Hirayasu Y, et al. (2004) Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study. Psychiatry Res 131, 195-207.
69. Rametti G, Segarra N, Junque C, et al. (2007) Left posterior hippocampal density reduction using VBM and stereological MRI procedures in schizophrenia. Schizophr Res 96, 62-71.
70. Pegues MP, Rogers LJ, Amend D, et al. (2003) Anterior hippocampal volume reduction in male patients with schizophrenia. Schizophr Res 60, 105-115.
71. Szeszko PR, Goldberg E, Gunduz-Bruce H, et al. (2003) Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia. Am J Psychiatry 160, 2190-2197.
72. Tregellas JR, Tanabe JL, Miller DE, et al. (2004) Neurobiology of smooth pursuit eye movement deficits in schizophrenia: an fMRI study. Am J Psychiatry 161, 315-321.
73. Eyler LT, Jeste DV, Brown GG (2008) Brain response abnormalities during verbal learning among patients with schizophrenia. Psychiatry Res 162, 11-25.
74. Kinney DK, Levy DL, Yurgelun-Todd DA et al. (1998) Inverse relationship of perinatal complications and eye tracking dysfunction in relatives of patients with schizophrenia: evidence for a two-factor model. Am J Psychiatry 155, 976-978.
75. John JP (2009) Fronto-temporal dysfunction in schizophrenia: A selective review. Indian J Psychiatry 51(3), 180-190.
76. Schlaepfer TE, Harris GJ, Tien AY et al. (1994) Decreased regional cortical gray matter volume in schizophrenia. Am J Psychiatry 151(6), 842-848.
77. Cannon TD, Thompson PM, van Erp TG et al. (2002) Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc Natl Acad Sci U S A 99(5):3228-3233.
78. Schmitt A, Weber-Fahr W, Jatzko A et al. (2001) Aktueller Ü berblick über strukturelle Magnetresonanztomographie bei Schizophrenie. Fortschritte der Neurologie Psychiatrie 69(3), 105-115.
79. Carter CS, Perlstein W, Ganguli R et al. (1998) Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry 155(9), 1285-1287.
80. Schröder J, Buchsbaum MS, Siegel BV et al. (1996) Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophr Res 19(1), 41-53.
81. Bilder RM, Wu H, Bogerts B et al. (1994) Absence of regional hemispheric volume asymmetries in first-episode schizophrenia. Am J Psychiatry 151(10), 1437-1447.
82. Vogeley K, Tepest R, Schneider-Axmann T et al. (2003) Automated image analysis of disturbed cytoarchitecture in Brodmann area 10 in schizophrenia. Schizophr Res 62, 133-140.
83. Sallet PC, Elkis H, Alves TM et al. (2003) Rdeuced cortical folding in schizophrenia: an MRI morphometric study. Am J Psychiatry 160(9), 1606-1613.
84. Falkai P, Honer WG, Kamer T et al. (2007) Disturbed frontal gyrification within families affected with schizophrenia. J Psychiatry Res 41(10), 805-813.
85. Stanfield AC, Moorhead TW, Harris JM et al. (2008) Invreased right prefrontal cortical folding in adolescents at risk of schizophrenia for cognitive reasons. Biol Psychiatry 63(1), 80-85.
86. McIntosh AM, Moorhead TW, McKirdy J et al. (2009) prefrontal gyral folding and its cognitive correlates in bipolar disorder and schizophrenia. Acta Psychiatr Scand 119(3), 192-198.
87. Noga JT, Aylward E, Barta PE, Pearlson GD (1995) Cingulate gyrus in schizophrenic patients and normal volunteers. Psychiatry Res 61(4), 201-208.
88. BaareWF, Pol HE, Hijman R et al. (1999) Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology. Biol Psychiatry 45(12):1597-1605.
89. Corcoran R, Frith CD (1993) Neuropsychology and neurophysiology in schizophrenia. Current Opinion in Psychiatry 6, 74-9.
90. Davis KL, Stewart DG, Friedman JI et al. (2003) White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry 60, 443-56.
91. Kalus P, Buri C, Slotboom J, et al. (2004) Volumetry and diffusion tensor imaging of hippocampal subregions in schizophrenia. Neuroreport 15, 867-871.
92. Kuroki N, Kubicki M, Nestor PG et al. (2006) Fornix integrity and hippocampal volume in male schizophrenic patients. Biol Psychiatry 60, 22-31.
93. White T, Kendi AT, Lehericy S et al. (2007) Disruption of hippocampal connectivity in children and adolescents with schizophrenia-a voxel-based diffusion tensor imaging study. Schizophr Res 90, 302-307.
94. Zhou Y, Shu N, Liu Y et al. (2008) Altered resting-state functional connectivity and anatomical connectivity of hippocampus in schizophrenia. Schizophr Res 100, 120-132.
95. Lim KO, Ardekani BA, Nierenberg J et al. (2006) Voxelwise correlational analyses of white matter integrity in multiple cognitive domains in schizophrenia. Am J Psychiatry 163, 2008-2010.
96. Kalus P, Slotboom J, Gallinat J et al. (2005) New evidence for involvement of the entorhinal region in schizophrenia: a combined MRI volumetric and DTI study. Neuroimage 24, 1122-1129.
97. Rajarethinam R, DeQuardo JR,Miedler J et al. (2001) Hippocampus and amygdala in schizophrenia: assessment of the relationship of neuroanatomy to psychopathology. Psychiatry Res 108, 79-87.
98. Harrison PJ (2004) The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 174, 151-162.
99. Goldman-Rakic PS, Selemon LD, Schwartz ML (1984) Dual pathways connecting the dorsolateral prefrontal cortexwith the hippocampal formation and parahippocampal cortex in the rhesus monkey. Neuroscience 12, 719-743.
100. Saccuzzo DP, Braff DL (1981) Early information processing deficit in schizophrenia. New findings using schizophrenic subgroups and manic control subjects. Arch Gen Psychiatry 38, 175-179.
101. Kerns JG, Cohen JD, MacDonald AW et al. (2004) Anterior cingulate conflict monitoring and adjustments in control. Science 303, 1023-1026.
102. Fincham JM, Anderson JR (2006) Distinct roles of the anterior cingulate and prefrontal cortex in the acquisition and performance of a cognitive skill. Proc Natl Acad Sci U S A 103, 12941-12946.
103. Pearlson GD, Petty RG, Ross CA, Tien AY (1996) Schizophrenia: a disease of heteromodal association cortex? Neuropsychopharmacology 14, 1-17.
104. Gruber O, von Cramon DY (2003) The functional neuroanatomy of human working memory revisited. Evidence from 3-T fMRI studies using classical domain-specific interference tasks. Neuroimage 19, 797-809.
105. Gruber O, Gurber E, Falkai P (2006) Articulatory rehearsal in verbal working memory: A possible neurocognitive endophenotype that differentiates between schizophrenia and schizoaffective disorder. Neurosci Lett 405, 24-28.
106. Henseler I, Falkai P, Gruber O (2009) Disturbed functional connectivity within brain networks subserving domain-specific subcomponents of working memory in schizophrenia: Relation to performance and clinical symptoms. J Psychiatr Res Oct 16 [Epub ahead of print]
107. Minzenberg MJ, Laird AR, Thelen S et al. (2009) meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch Gen Psychiatry 66(8), 811-822.
108. Gaser C, Nenadic I, Volz HP et al. (2004) Neuroanatomy of 'hearing voices': a frontotemporal brain structural abnormality associated with auditory hallucinations in schizophrenia. Cereb Cortex 14(1):91-96.
109. Brickman AM, Buchsbaum MS, Shihabuddin L et al. (2004) Thalamus size and outcome in schizophrenia. Schizophr Res 71, 473-484.
110. Gur RE, Maany V,Mozley PD et al. (1998) Subcortical MRI volumes in neurolepticna ïve and treated patients with schizophrenia. Am J Psychiatry 155(12), 1711-1717.
111. Carlsson A, Waters N, Carlsson ML (1999) Neurotransmitter interactions in schizophrenia-therapeutic implications. Eur Arch Psychiatry Clin Neurosci 249(Suppl 4), IV37-IV/43.
112. Tekin S, Cummings JL. (2002) Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 53(2), 647-654.
113. Taber KH, Wen C, Khan A, Hurley RA (2004) The limbic thalamus. J Neuropsychiatry Clin Neurosci 16(2), 127-132.
114. Lang DJ, Khorram B, Goghari VM, et al. (2006) Reduced anterior internal capsule and thalamic volumes in first-episode psychosis. Schizophr Res 87, 89-99.
115. Ettinger U, Picchioni M, Landau S et al. (2007) Magnetic resonance imaging of the thalamus and adhesio interthalamica in twins with schizophrenia. Arch Gen Psychiatry 64(4), 401-409.
116. Andreasen NC, Arndt S, Swayze V, 2nd et al. (1994) Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 266, 294-298.
117. Andreasen NC, Nopoulos P, O'Leary DS et al. (1999) Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry 46, 908-920.
118. Min SK, An SK, Jon DI, Lee JD (1999) Positive and negative symptoms and regional cerebral perfusion in antipsychotic-naive schizophrenic patients: a high-resolution SPECT study. Psychiatry Res 90(3), 159-168.
119. Takahashi H, Koeda M, Oda K et al. (2004) An fMRI study of differential neural response to affective pictures in schizophrenia. Neuroimage 22, 1247-1254.
120. Butler PD, Zemon V, Schechter I et al. (2005) Early-stage visual processing and cortical amplification deficits in schizophrenia. Arch Gen Psychiatry 62, 495-504.
121. Kiehl KA, Stevens MC, Celone K et al. (2005) Abnormal hemodynamics in schizophrenia during an auditory oddball task. Biol Psychiatry 57, 1029-1040.
122. Braus DF, Weber-Fahr W, Tost H et al. (2002) Sensory information processing in neuroleptic-naive first-episode schizophrenic patients: a functional magnetic resonance imaging study. Arch Gen Psychiatry 59, 696-701.
123. Schmitt A, Otto S, Jatzko A et al. (2009) [Parieto-prefrontal dysfunction during visuo-auditory information processing in elderly, chronic schizophrenic patients and medication effects]. Revista de Psiquiatria Clinica 36(3), 89-96.
124. Schneider F, Habel U, Klein M et al. (2007) Neural correlates of working memory dysfunctions in first-episode schizophrenia patients: An fMRI multicenter study. Schizophrenia Research 89, 198-210.
125. Gundersen HJ, Bagger P, Bendtsen TF et al. (1988) The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. Apmis 96, 857-881.
126. Williams RW, Rakic P (1988) Three-dimensional counting: an accurate and direct method to estimate numbers of cells in sectioned material. J Comp Neurol 278, 344-352.
127. Falkai, P, Bogerts B (1986) Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci 236, 154-161.
128. Benes FM, Bird ED(1987) An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch Gen Psychiatry 44, 608-616.
129. Falkai, P, Bogerts, B, Rozumek M (1988) Limbic pathology in schizophrenia: the entorhinal region-a morphometric study. Biol Psychiatry 24, 515-521.
130. Weinberger DR (1999) Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 45, 395-402.
131. Jakob H, Beckmann H (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65, 303-326.
132. Falkai P, Schneider-Axmann T, Honer WG (2000) Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality. Biol Psychiatry 47, 937-943.
133. Kovalenko S, Bergmann A, Schneider-Axmann T et al. (2003) Regio entorhinalis in schizophrenia: more evidence for migrational disturbances and suggestions for a new biological hypothesis. Pharmacopsychiatry 36 Suppl 3, S158-16.1
134. Hurlemann R, Tepest R, Maier W et al. (2005) Intact hippocampal gray matter in schizophrenia as revealed by automatized image analysis postmortem. Anat Embryol (Berl) 210, 513-517.
135. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS (1998) A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 44, 88-97.
136. Zhang ZJ, Reynolds GP (2002) A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res 55, 1-10.
137. Arnold SE, Franz BR, Gur RC, et al. (1995) Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry 152, 738-748.
138. Dwork AJ (1997) Postmortem studies of the hippocampal formation in schizophrenia. Schizophr Bull 23, 385-402.
139. Benes FM (1991) Evidence for neurodevelopment disturbances in anterior cingulate cortex of post-mortem schizophrenic brain. Schizophr Res 5, 187-188.
140. Zaidel DW, Esiri MM, Harrison PJ (1997) Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia. Am J Psychiatry 154, 812-818.
141. Highley JR, Walker MA, McDonald B, et al. (2003) Size of hippocampal pyramidal neurons in schizophrenia. Br J Psychiatry 183, 414-417.
142. Casanova MF, Stevens JR, Kleinman JE (1990) Astrocytosis in the molecular layer of the dentate gyrus: a study in Alzheimer's disease and schizophrenia. Psychiatry Res 35, 149-166.
143. Falkai P, Honer WG, David S, et al. (1999) No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study. Neuropathol Appl Neurobiol 25, 48-53.
144. Schmitt A, Steyskal C, Bernstein HG, et al. (2009) Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta Neuropathologica 117(4), 395-407.
145. Steiner J, Bernstein HG, Bielau H et al. (2008) S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study. J Psychiatr Res 42(10), 868-876.
146. Heckers S, Heinsen H, Geiger B, et al. (1991) Hippocampal neuron number in schizophrenia. A stereological study. Arch Gen Psychiatry 48, 1002-1008.
147. Zhang Z, Sun J, Reynolds GP (2002) A selective reduction in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia patients. Chinese Medical Journal 115, 819-823.
148. Walker MA, Highley JR, Esiri MM, et al. (2002) Estimated neuronal populations and volumes of the hippocampus and its subfields in schizophrenia. Am J Psychiatry 159, 821-828.
149. Bartzokis G, Nuechterlein KH, Lu PH, et al. (2003) Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. Biol Psychiatry 53, 412-421.
150. Kolomeets NS, Uranova NA (2008) [Pathology of oligodendroglia and myelinated fibers of the hippocampus in schizophrenia (an ultrastructural and morphometric study)]. Zh Nevrol Psikhiatr Im S S Korsakova 108, 52-60.
151. Brodmann K (1025) Vergleichende Lokalisationslehre der Großhirnrinde. Barth.
152. Kawasak Y, Vogeley K, Jun V et al. (2000) Automated image analysis of disturbed cytoarchitecture in Brodmann area 10 in schizophrenia: a post-mortem study. Prog Neuropsychopharmacol Biol Psychiatry 24, 1093-1111.
153. Vogeley K, Tepest R, Schneider-Axmann T et al. (2003) Automated image analysis of disturbed cytoarchitecture in Brodmann area 10 in schizophrenia. Schizophr Res 62, 133-140.
154. Tepest R, Vogeley K, Viebahn B et al. (2008) Automated gray level index measurements reveal only minor cytoarchitectonic changes of Brodmann area 9 in schizophrenia. Psychiatry Res 163(2), 183-192.
155. Selemon LD, Rajkowska G, Goldman-Rakic PS (1995) Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 52, 805-818; discussion 819-820.
156. Selemon LD, Mrzljak J, Kleinman JE et al. (2003) Regional specificity in the neuropathologic substrates of schizophrenia: a morphometric analysis of Broca's area 44 and area 9. Arch Gen Psychiatry 60, 69-77.
157. Pierri JN, Volk CL, Auh S et al. (2001) Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry 58, 466-473.
158. Rajkowska G, Miguel-Hidalgo JJ, Makkos Z et al. (2002) Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr Res 57, 127-138.
159. Hof PR, Haroutunian V, Copland C et al. (2002) Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem Res 27, 1193-1200.
160. Hof PR, Haroutunian V, Friedrich VL, Jr. et al. (2003). Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 53, 1075-1085.
161. Bouras C, Kovari E, Hof PR et al. (2001) Anterior cingulate cortex pathology in schizophrenia and bipolar disorder. Acta Neuropathol (Berl) 102, 373-379.
162. Stark AK, Uylings HB, Sanz-Arigita E et al. (2004) Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am J Psychiatry 161, 882-888.
163. Segal D, Schmitz C, Hof PR (2009) Spatial distribution and density of oligodendrocytes in the cingulum bundle are unaltered in schizophrenia. Acta Neuropathol 117(4), 385-394.
164. Vostrikov VM, Uranova NA, Orlovskaya DD (2007) Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders. Schizophr Res 94(1-3), 273-280.
165. Beasley CL, Chana G, Honavar M et al. (2005) Evidence for altered neuronal organisation within the planum temporale in major psychiatric disorders. Schizophr Res 73, 69-78.
166. Cotter D, Mackay D, Frangou S et al. (2004) Cell density and cortical thickness in Heschl's gyrus in schizophrenia, major depression and bipolar disorder. Br J Psychiatry 185, 258-259.
167. Uranova N, Orlovskaya D, Vikhreva O et al. (2001) Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull 55, 597-610.
168. Uranova NA, Vostrikov VM, Vikhreva OV et al. (2007) The role of oligodendrocyte pathology in schizophrenia. Int J Neuropsychopharmacol 10, 537-545.
169. Yakovlev PI, Lecours AR (1967) The myelogenetic cycles of regional maturation of the brain. Blackwell Scientific Publications, 3-70.
170. Lewis DA, Cruz DA, Melchitzky DS, Pierri JN (2001) Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. Am J Psychiatry 158, 1411-1422.
171. Pakkenberg B (1990) Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 47, 1023-1028.
172. Danos P, Baumann B, BernsteinHGet al. (2002) The ventral lateral posterior nucleus of the thalamus in schizophrenia: a post-mortem study. Psychiatry Res 114, 1-9.
173. Popken GJ, Bunney WE Jr, Potkin SG, Jones EG (2000) Subnucleus-specific loss of neurons in the medial thalamus of schizophrenics. PNAS 97, 9276-9280.
174. Young KA, Manaye KF, Liang C et al. (2000) Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol Psychiatry 47, 944-953.
175. Byne W, Buchsbaum MS, Mattiace LA et al. (2002) Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am J Psychiatry 159, 59-65.
176. Danos P, Baumann B, Krämer A et al. (2003) Volumes of association thalamic nuclei in schizophrenia: a postmortem study. Schizophr Res 60, 141-155.
177. Weinberger DR (1996) On the plausibility of 'the neurodevelopmental hypothesis'of schizophrenia. Neuropsychopharmacology 14, 1S-11S.
178. Steen RG,Mull C,McClure R et al. (2006) Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 188, 510-518.
179. Vita A, De Peri L, Lilenzi C, Dierci M (2006) Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res 82(1), 75-88.
180. Ellison-Wright I, Glahn DC, Laird AR et al. (2008) The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 165(8), 1015-1023.
181. DeLisi LE, Tew W, Xie S et al. (1995) A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. Biol Psychiatry 38, 349-360.
182. DeLisi LE, Sakuma M, Tew W (1997) Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res 74, 129-140.
183. Nair TR, Christensen JD,Kingsbury SJ et al. (1997) progression of cerebroventricular enlargement and the subtyping of schizophrenia. Psychiatry Res 74(3), 141-150.
184. Gur RE, Cowell P, Turetsky BI et al. (1998)Afollow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry 55(2), 145-152.
185. Woods BT (1998) is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry 155, 1661-1670.
186. Ho BC, Andreasen NC, Nopoulos P et al. (2003) Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry 60(6), 585-594.
187. DeLisi LE, Sakuma M, Maurizio AM et al. (2004) Cerebral ventricular change over the first 10 years after the onset of schizophrenia. Psychiatry Res 130, 57-70.
188. Whitford TJ, Grieve SM, Farrow TF et al. (2006) Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: A tensor-based morphometry study. Neuroimage 32(2), 511-519.
189. Koo MS, Levitt JJ, Salisbury DF et al. (2008) A cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Arch Gen Psychiatry 65(7), 746-760.
190. Hulshoff Pol HE, Kahn RS. (2008) What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr Bull 34(2), 354-366.
191. Takahashi T, Wood SJ, Soulsby B et al. (2009) Follow-up MRI study of the insular cortex in first-episode psychosis and chronic schizophrenia. Schizophr Res 108(1-3), 49-56.
192. Mane A, Falcon C, Mateos JJ et al. (2009) progressive gray matter
193. Takahashi T, Suzuki M, Zhou SY et al. (2010) A follow-up MRI study of the superior temporal subregions in schizotypal disorder and first-episode schizophrenia. Schizophr Res Jan 3 [Epub ahead of print].
194. Van Haren NE, Hulshoff Pol HE, Schnack HG et al. (2008) progressive brain volume loss in schizophrenia over the course of the illness. Evidence of maturational abnormalities in early adulthood. Biol Psychiatry 63(1), 106-113.
195. Kasparek T, Prikryl R, Schwarz D et al. (2009) Gray matter morphology and the level of functioning in one-year follow-up of first-episode schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry 33(8), 1438-1446.
196. Sun D, Phillips L, Velakoulis D et al. (2009) Progressive brain structural changes mapped as psychosis develops in 'at risk'individuals. Schizophr Res 108(1-3): 85-92.
197. Sun D, Stuart GW, Jenkinson M et al. (2009) Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Mol Psychiatry 14(10):976-986.
198. Akbarian S, Kim JJ, Potkin SG et al. (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52, 258-266.
199. Thune JJ, Hofsten DE, Uylings HBM et al. (1998) Total neuron numbers in the prefrontal cortex in schizophrenia. Soc Neurosci Abstracts 24, 437-458.
200. Goldman-Rakic PS, Selemon LD (1997) Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr Bull, 23, 437-358.
201. Glantz LA, Lewis DA (2000) Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 57, 65-73.
202. Stephan KE, Baldeweg T, Friston KJ (2006) Synaptic plasticity and dysconnection in schizophrenia. Biol Psychiatry 59, 929-939.
203. Eastwood SL, Cairns NJ, Harrison PJ (2000) Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex. Br J Psychiatry 176, 236-242.
204. Eastwood SL, Harrison PJ (2000) Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol Psychiatry 5(4):425-432.
205. Eastwood SL, Harrison PJ (2001) Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res Bull 55(5):569-578.
206. Eastwood SL, Harrison PJ (2005) Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophr Res 73(2-3):159-172.
207. Honer WG, Falkai P, Bayer TA et al. (2002) Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cereb Cortex 12(4):349-356.
208. Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, Torrey EF, Stanley Neuropathology Consortium. (2004) Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 9(6):609-620.
209. Kuromitsu J, Yokoi A, Kawai T et al. (2001) Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder. Brain Res Gene Expr Patterns 1(1):17-21.
210. Sawada K, Barr AM, Nakamura M et al. (2005) Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch Gen Psychiatry 62(3):263-272.
211. Sawada K, Young CE, BarrAMet al. (2002) Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness. Mol Psychiatry 7(5):484-492.
212. Sokolov BP, Tcherepanov AA, Haroutunian V, Davis KL (2000) Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients. Biol Psychiatry 48(3):184-196.
213. Brose N (2008) Altered complexin expression in psychiatric and neurological disorders: cause or consequence? Mol Cells 25(1):7-19.
214. Maycox PR, Kelly F, Taylor A et al. (2009) Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry 14(12), 1083-1094.
215. Glantz LA, Lewis DA (1997) Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry 54, 943-952.
216. Honer WG, Falkai P, Chen C (1999) Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience 91(4), 1247-1255.
217. Fatemi SH, Earle JA, Stary JM, Lee S, Sedgewick J (2001) Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. Neuroreport 12(15), 3257-3262.
218. Thompson PM, Sower AC, Perrone-Bizzozero NI (1998) Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biol Psychiatry 43(4), 239-243.
219. Halim ND, Weickert CS, McClintock BW et al. (2003) Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development. Mol Psychiatry 8(9), 797-810.
220. Young CE, Arima K, Xie J et al. (1998) SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cereb Cortex 8(3), 261-268.
221. Harrison PJ, Eastwood SL (2001) Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 11(5), 508-519.
222. Conover JC, Allen RL (2002) The subventricular zone: new molecular and cellular developments. Cell Mol Life Sci 59(12), 2128-2135.
223. Reif A, Fritzen S, Finger M et al. (2006) Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry 11, 514-522.
224. Kalkman HO (2009) Altered growth factor signalling pathways as the basis of aberrant stem cell maturation in schizophrenia. Pharmacology and Therapeutics 121, 115-122.
225. Cannon TD, Hennah W, van Erp TG et al. (2005) Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired shortand long-term memory. Arch Gen Psychiatry 62(11), 1205-1213.
226. Li W, Zhou Y, Jentsch JD et al. (2007) Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proc Natl Acad Sci U SA 104(46), 18280-18285.
227. Braus DF, Brassen S (2005) [Functional magnetic resonance imaging and antipsychotics. Overview and own data]. Radiologe 45, 178-185.
228. Jones HM, Brammer MJ, O'Toole M et al. (2004) Cortical effects of quetiapine in first-episode schizophrenia: a preliminary functional magnetic resonance imaging study. Biol Psychiatry 56, 938-942.
229. Snitz BE, MacDonald A, 3rd, Cohen JD et al. (2005) Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment. Am J Psychiatry 162, 2322-2329.
230. Davis CE, JesteDV, Eyler LT (2005) Reviewof longitudinal functional neuroimaging studies of drug treatments in patients with schizophrenia. Schizophrenia Research 78, 45-60.
231. Braus DF, Ende G, Hubrich-Ungureanu P, Henn FA (2000) Cortical response to motor stimulation in neuroleptic-naive first episode schizophrenics. Psychiatry Res 98, 145-54.
232. Honey GD, Bullmore ET, Soni W et al. (1999) Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc Natl Acad Sci U S A 96, 13432-13437.
233. Ojeda N, Ortuno F, Arbizu J et al. (2002) Functional neuroanatomy of sustained attention in schizophrenia: contribution of parietal cortices. Hum Brain Mapp 17, 116-130.
234. Weiss EM, Siedentopf C, Golaszewski S et al. (2007) Brain activation patterns during a selective attention test-a functional MRI study in healthy volunteers and unmedicated patients during an acute episode of schizophrenia. Psychiatry Res 154, 31-40.
235. Tost H, Meyer-Lindenberg, Klein S et al. (2006) D2 antidopaminergic modulation of frontal lobe functions in healthy subjects. Biol Psychiatry 60(11), 1196-1205.
236. MehtaMA, Manes FF, MagnolfiG et al. (2004) Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers. Psychopharmacology (Berl) 176, 331-342.
237. Goto Y, Grace AA (2005) Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior. Nat Neurosci 8, 805-812.
238. Floresco SB, Magyar O (2006) Mesocortical dopamine modulation of executive functions: beyond working memory. Psychopharmacology (Berl) 188, 567-585.
239. Konopaske GT, Dorph-Petersen KA, Pierri JN et al. (2007) Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology 32, 1216-1223.
240. Konopaske GT, Dorph-Petersen KA, Sweet RA et al. (2008) Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry 63, 759-765.
241. Newton SS, Duman RS (2007) Neurogenic actions of atypical antipsychotic drugs and therapeutic implications. CNS Drugs 21(9), 715-725.
242. Eastwood SL, Brunet PWJ, Harrison PJ (2000) Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain. Synapse 36, 167-177.
243. Schmitt A, Zink M, Müller B et al. (2003) Effects of long-term antipsychotic treatment on NMDA receptor binding and gene expression of subunits. Neurochemical Research 28(2), 235-241.
244. Carlsson A (2001) A paradigm shift in brain research. Science 294, 1021-102.
245. Schmitt A, Zink M, May B et al. (2003) Decreased gene expression of glial and neuronal glutamate transporters after antipsychotic treatment in rat brain. Neuroscience Letters 347(2), 81-84.
246. Adamcio B, Sargin D, Stradomska A et al. (2008) Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biol 9, 6-37.
247. Millan MJ (2005) N-methyl-D-aspartate receptors as target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology 179(1):30-53.
248. Hajos M, Rogers BN (2009) Targeting alpha7 nicotinic acetylcholine receptors in the treatment of schizophrenia. Curr Pharm Des Nov 12 [Epub ahead of print].
249. Pajonk F, Wobrock T, Gruber O et al. (2009) Hippocampal plasticity in response to exercise in schizophrenia. Arch Gen Psychiatry 67(2), 133-143.
250. Hu S, Ying Z, Gomez-Pinilla F, Frautschy SA (2009) Exercise can increase small heat shock proteins (sHSP) and pre-and post-synaptic proteins in the hippocampus. Brain Research, 1249, 191-201.